Mettler-Toledo International (NYSE:MTD) Stock Price Target Raised at JPMorgan Chase & Co.

Key Points

• JPMorgan raised its price target on Mettler-Toledo to $1,725 from $1,550 but maintained a neutral rating; the new target implies about 2.1% downside from the stock’s current price.
• Analyst sentiment is mixed: the consensus rating is “Hold,” with an average price target of $1,595.77; six analysts rate the stock Buy, eight Hold, and one Sell.
• Mettler-Toledo beat quarterly expectations, reporting earnings of $12.57 per share and $1.09 billion in revenue. Revenue increased 6.3% year over year.

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its target price raised by analysts at JPMorgan Chase & Co. from $1,550.00 to $1,725.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has a "neutral" rating on the medical instruments supplier's stock. JPMorgan Chase & Co.'s target price suggests a potential downside of 2.10% from the stock's current price.

MTD has been the subject of a number of other reports. Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an "equal weight" rating in a report on Monday, August 3rd. Weiss Ratings raised Mettler-Toledo International from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Monday, October 19th. Jefferies Financial Group lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a "buy" rating in a research note on Friday, July 31st. Rothschild & Co Redburn began coverage on Mettler-Toledo International in a research report on Wednesday, September 2nd. They set a "sell" rating and a $1,200.00 price objective for the company. Finally, Morgan Stanley upped their target price on shares of Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the stock an "equal weight" rating in a research note on Tuesday, October 13th. Six investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Hold" and an average price target of $1,595.77.

Mettler-Toledo International Stock Performance

NYSE MTD traded up $39.88 on Monday, hitting $1,762.04. 127,005 shares of the company's stock traded hands, compared to its average volume of 184,158. The company has a current ratio of 1.10, a quick ratio of 0.75 and a debt-to-equity ratio of 25.28. Mettler-Toledo International has a 1-year low of $1,023.05 and a 1-year high of $1,806.58. The firm's 50-day moving average price is $1,524.65 and its two-hundred day moving average price is $1,345.95. The firm has a market capitalization of $35.31 billion, a PE ratio of 38.27, a P/E/G ratio of 3.46 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share for the quarter, topping analysts' consensus estimates of $12.13 by $0.44. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same quarter in the prior year, the business earned $11.15 earnings per share. The business's quarterly revenue was up 6.3% compared to the same quarter last year. As a group, analysts expect that Mettler-Toledo International will post 47.49 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In other news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the transaction, the chief executive officer owned 4,480 shares in the company, valued at approximately $6,384,000. This represents a 17.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.71% of the stock is owned by company insiders.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MTD. Edmond DE Rothschild Holding S.A. acquired a new stake in Mettler-Toledo International during the 2nd quarter worth $26,000. Transamerica Financial Advisors LLC acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at about $32,000. Provenance Wealth Advisors LLC acquired a new stake in shares of Mettler-Toledo International in the 3rd quarter valued at about $54,000. Principia Wealth Advisory LLC grew its stake in Mettler-Toledo International by 2,050.0% during the 2nd quarter. Principia Wealth Advisory LLC now owns 43 shares of the medical instruments supplier's stock worth $55,000 after buying an additional 41 shares during the last quarter. Finally, Root Financial Partners LLC purchased a new position in Mettler-Toledo International during the 3rd quarter worth approximately $56,000. 95.07% of the stock is owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.

The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.